SHELTON, CT / ACCESS Newswire / July 21, 2025 / NanoViricides, Inc., a publicly traded company (NYSE Amer.: NNVC ) (the ...

Earlier this summer the FDA asked Moderna for more efficacy data on its flu vaccine before it could review an mRNA-based ...

By Howard Whiteman Murray State University Last week my research students and I were carefully searching a beaver pond for ...

AI also supports reverse vaccinology, where pathogen genomes are computationally analyzed to identify immunogenic regions ...

University of Florida scientists have engineered an experimental mRNA vaccine that stimulates the immune system to combat ...

Following on from their breakthrough human trial that successfully reprogrammed the immune system to overpower glioblastoma, ...

Moderna, already in cash-saving mode amid uncertain vaccine dynamics, is backing off from its plans to construct an mRNA drug ...

A promising new COVID-19 vaccine candidate developed by researchers at the Centenary Institute and the University of Sydney ...

Discover how Genome Valley is emerging as an essential partner in global biopharma and how it is now venturing into cell and ...

Researchers from Cornell and Northwestern universities have developed a rapid, cell-free method for building nanoparticle ...

Researchers from the Centenary Institute and the University of Sydney created the CoVEXS5 vaccine, which protects against ...